LONG-TERM TOLERABILITY AND SAFETY OF ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER

被引：0
|
作者：
Forbes, Robert A. [1 ]
Nyilas, M. [1 ]
Johnson, B. [1 ]
Aurang, C. [1 ]
Owen, R. [2 ]
Iwamoto, T. [1 ]
Carson, W. H. [1 ]
Correll, C. [3 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat, Clin Dev, Global Med Affairs, Princeton, NJ USA
[2] Bristol Myers Squibb Co, Clin Dev, Wallingford, CT 06492 USA
[3] Zucker Hillside Hosp, Glen Oaks, NY USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [1] Long-term tolerability and safety of aripiprazole in pediatric patients with schizophrenia or bipolar I disorder
    Nyilas, M.
    Correll, C.
    Werner, C.
    Forbes, R.
    Johnson, B.
    Aurang, C.
    Jin, N.
    Owen, R.
    Iwamoto, T.
    Carson, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 133 - 134
  • [2] Efficacy and tolerability of long-term aripiprazole treatment in a patient with bipolar I disorder
    De Berardis, D.
    Serroni, N.
    Campanella, D.
    Moschetta, F. S.
    Ferro, F. M.
    JOURNAL OF PSYCHOPATHOLOGY, 2009, 15 (01): : 99 - 101
  • [3] Long-term efficacy of aripiprazole in pediatric patients with bipolar I disorder
    Forbes, R.
    Werner, C.
    Nyilas, M.
    Jin, N.
    Johnson, B.
    Owen, R.
    Iwamoto, T.
    Carson, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 184 - 184
  • [4] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [5] Long-Term Safety and Tolerability of Aripiprazole in Children (10-17 Years) With Bipolar I Disorder
    Nyilas, Margaretta
    Forbes, Andy
    Ashfaque, Shahid
    Jin, Na
    Aurang, Catherine
    Johnson, Brian
    McQuade, Robert
    Owen, Randall
    Carson, William H.
    Correll, Christoph U.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 636 - 636
  • [6] Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia
    Riccobene, Todd
    Riesenberg, Robert
    Yeung, Paul P.
    Earley, Willie R.
    Hankinson, Arlene L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (08) : 434 - 443
  • [7] Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Johnson, Brian
    Jin, Na
    Forbes, Robert A.
    McQuade, Robert
    Baker, Ross A.
    Carson, William
    Kane, John M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (04) : 171 - 176
  • [8] PHARMACOKINETICS AND SAFETY/TOLERABILITY PROFILE OF CARIPRAZINE IN PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
    Riccobene, Todd
    Riesenberg, Robert
    Yeung, Paul
    Earley, Willlie
    Hankinson, Arlene
    Periclou, Antonia
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S171 - S171
  • [9] Aripiprazole in combination with lamotrigine: long-term treatment of patients with bipolar I disorder (manic or mixed)
    Ketter, T.
    Carlson, B. X.
    Sun, W.
    Timko, K.
    Vester-Blokland, E.
    McQuade, R. D.
    Sanchez, R.
    Owen, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S413 - S414
  • [10] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G.
    Lu, K.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    BIPOLAR DISORDERS, 2013, 15 : 134 - 134
12345